Bionano Genomics (BNGO) vs Quanterix (QTRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Bionano Genomics (BNGO) has outperformed Quanterix (QTRX) over the past year, losing 26.3% versus a loss of 46.5%. Over five years, QTRX leads with a -93.8% price change compared with -100.0% for BNGO. Quanterix is the larger company by market cap ($155.6 million vs $17.4 million), about 8.9 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BNGO | QTRX |
|---|---|---|
| Share price | $1.48 | $3.29 |
| Market cap | $17.43M | $155.59M |
| 1-day change | +1.37% | +2.49% |
| YTD return | -4.58% | -49.53% |
| 1-year return | -26.26% | -46.50% |
| 5-year return | -99.95% | -93.79% |
| EPS (TTM) | $-3.02 | $-2.61 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.23 | $8.77 |
| 52-week low | $1.00 | $2.15 |
| Distance from 52-week high | -33.63% | -62.49% |
| Analyst consensus | none | none |
| Avg. price target upside | +237.84% | -8.81% |
| Average volume | 921.59K | 764.39K |
| Shares outstanding | 11.78M | 47.29M |
| Employees | 95 | 450 |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Quanterix is about 8.9 times larger than Bionano Genomics by market value ($155.59M vs $17.43M).
- BNGO has outperformed QTRX by 20.2 percentage points over the past year.
About Bionano Genomics
BNGO stock →Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, China, Japan, South Korea, Singapore, India, and Australia. The company offers genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants.
Industrials · Biotechnology: Laboratory Analytical Instruments · 95 employees
About Quanterix
QTRX stock →Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.
Industrials · Biotechnology: Laboratory Analytical Instruments · 450 employees
BNGO vs QTRX FAQ
Which is bigger, Bionano Genomics or Quanterix?
Quanterix (QTRX) is larger, with a market capitalization of $155.59M compared with $17.43M for Bionano Genomics (BNGO).
Which stock has performed better over the past year, BNGO or QTRX?
BNGO returned -26.26% over the past 12 months, compared with -46.50% for QTRX (price return, excluding dividends). Past performance does not predict future results.
Are Bionano Genomics and Quanterix in the same industry?
Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.